We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+19.09%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.27B
AUM Growth
-$5.76B
Cap. Flow
-$1.51B
Cap. Flow %
-46.09%
Top 10 Hldgs %
34.23%
Holding
5,681
New
749
Increased
1,274
Reduced
3,081
Closed
446

Sector Composition

Rank Sector Weight
1 Technology 9.66%
2 Financials 8.46%
3 Healthcare 8.24%
4 Consumer Discretionary 7.74%
5 Industrials 6.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CIXX
3526
DELISTED
CI Financial Corp.
CIXX
$32K ﹤0.01%
+2,600
New +$33.8K
EMWP
3527
DELISTED
Eros Media World PLC
EMWP
$32K ﹤0.01%
882
-4,938
-85% -$215K
RRD
3528
DELISTED
RR Donnelley & Sons Co.
RRD
$32K ﹤0.01%
+14,184
New +$21.3K
NWHM
3529
DELISTED
THE NEW HOME COMPANY INC.
NWHM
$32K ﹤0.01%
6,895
+6,871
+28,629% +$36.4K
SCPE
3530
DELISTED
SC Health Corporation
SCPE
$32K ﹤0.01%
3,155
-233
-7% -$2.36K
UBOH
3531
DELISTED
United Bancshares Inc/OH
UBOH
$32K ﹤0.01%
1,231
+925
+302% +$20.9K
ANIP icon
3532
ANI Pharmaceuticals
ANIP
$1.72B
$31K ﹤0.01%
1,068
-7,665
-88% -$220K
CBFV icon
3533
CB Financial Services
CBFV
$190M
$31K ﹤0.01%
1,524
-3,125
-67% -$65.6K
CDC icon
3534
VictoryShares US EQ Income Enhanced Volatility Wtd ETF
CDC
$753M
$31K ﹤0.01%
578
-15,443
-96% -$790K
CSBR icon
3535
Champions Oncology
CSBR
$70.6M
$31K ﹤0.01%
2,880
-3,963
-58% -$40.9K
CSR
3536
Centerspace
CSR
$939M
$31K ﹤0.01%
444
-3,164
-88% -$222K
CTOS icon
3537
Custom Truck One Source
CTOS
$2.33B
$31K ﹤0.01%
4,197
-9,762
-70% -$49.4K
CXDO icon
3538
Crexendo
CXDO
$217M
$31K ﹤0.01%
4,468
+3,253
+268% +$21.2K
EPM icon
3539
Evolution Petroleum
EPM
$135M
$31K ﹤0.01%
11,006
-23,262
-68% -$58.9K
GSHD icon
3540
Goosehead Insurance
GSHD
$2.39B
$31K ﹤0.01%
247
-12,954
-98% -$1.48M
INVA icon
3541
Innoviva
INVA
$1.5B
$31K ﹤0.01%
2,462
-41,970
-94% -$453K
LADR
3542
Ladder Capital
LADR
$1.27B
$31K ﹤0.01%
3,131
-141,253
-98% -$1.2M
LX
3543
LexinFintech Holdings
LX
$236M
$31K ﹤0.01%
4,670
-900
-16% -$6.44K
NGNE icon
3544
Neurogene
NGNE
$713M
$31K ﹤0.01%
109
-1,195
-92% -$292K
PSI icon
3545
Invesco Semiconductors ETF
PSI
$2.59B
$31K ﹤0.01%
894
-20,427
-96% -$628K
RMTI icon
3546
Rockwell Medical
RMTI
$30.9M
$31K ﹤0.01%
280
-423
-60% -$47.4K
SILC icon
3547
Silicom
SILC
$258M
$31K ﹤0.01%
737
+640
+660% +$24K
TZOO icon
3548
Travelzoo
TZOO
$74.4M
$31K ﹤0.01%
3,336
+2,571
+336% +$22.1K
UAMY icon
3549
United States Antimony
UAMY
$799M
$31K ﹤0.01%
58,987
+34,241
+138% +$13.9K
ARQ icon
3550
Arq
ARQ
$99.6M
$31K ﹤0.01%
5,627
-12,579
-69% -$64K

Similar funds

Tower Research Capital (TRC)'s Q4 2020 Portfolio in Review

As of Q4 2020, Tower Research Capital (TRC) held 5,681 positions worth $3.27B, down 64% from $9.03B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Tower Research Capital (TRC) withdrew a net $1.51B in Q4 2020, closing 446 positions and reducing 3,081 holdings. Its most notable exit was iShares Russell 2000 Growth ETF, an estimated $13.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 6.3% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Russell 1000 ETF worth $24.4M.

  • Tower Research Capital (TRC)'s largest Q4 2020 buy was iShares Russell 1000 ETF: 115,321 shares worth $24.4M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $99.8M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2020 reduction was iShares Russell 2000 ETF, cutting an estimated $36.3M.
  • Tower Research Capital (TRC) fully exited iShares Russell 2000 Growth ETF in Q4 2020, selling an estimated $13.7M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 34% of its $3.27B portfolio in Q4 2020.
  • Tower Research Capital (TRC) opened 749 new positions and closed 446 in Q4 2020.
  • Tower Research Capital (TRC)'s portfolio value fell 64% quarter-over-quarter to $3.27B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2020, filed 16 Feb 2021.